MARC details
000 -LEADER |
fixed length control field |
02327nam a22004457a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
190314s20192019 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
0889-8529 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1016/j.ecl.2018.11.005 [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
S0889-8529(18)30592-9 [pii] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
30717901 |
245 ## - TITLE STATEMENT |
Title |
Conventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review] |
251 ## - Source |
Source |
Endocrinology & Metabolism Clinics of North America. 48(1):181-197, 2019 03. |
252 ## - Abbreviated Source |
Abbreviated source |
Endocrinol Metab Clin North Am. 48(1):181-197, 2019 03. |
253 ## - Journal Name |
Journal name |
Endocrinology and metabolism clinics of North America |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2019 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2019 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
ppublish |
266 ## - Date added to catalog |
Date added to catalog |
2019-03-14 |
501 ## - WITH NOTE |
Local holdings |
Available online from MWHC library: 1996 - present |
520 ## - SUMMARY, ETC. |
Abstract |
Copyright (c) 2018 Elsevier Inc. All rights reserved. |
520 ## - SUMMARY, ETC. |
Abstract |
This article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients with differentiated thyroid cancer. Topics reviewed include definitions; staging; the 2 principal methods for selection of 131-I dosage; the indications for ablation, adjuvant treatment, and treatment; the recommendations for the use of 131-I contained in the guidelines of the American Thyroid Association and the Society of Nuclear Medicine and Molecular Imaging; the dosage recommendations and selection of dosage approach for 131-I by these organizations; the use of recombinant human thyrotropin for radioiodine ablation, adjuvant therapy, or treatment; and the MedStar Washington Hospital Center approach. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Iodine Radioisotopes/tu [Therapeutic Use] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
*Thyroid Neoplasms/rt [Radiotherapy] |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Humans |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Iodine Radioisotopes/ad [Administration & Dosage] |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Health Research Institute |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Washington Hospital Center |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine/Endocrinology |
656 ## - INDEX TERM--OCCUPATION |
Department |
Medicine/Nuclear Medicine |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Journal Article |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Review |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Van Nostrand, Douglas |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Wartofsky, Leonard |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Ylli, Dorina |
790 ## - Authors |
All authors |
Van Nostrand D, Wartofsky L, Ylli D |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1016/j.ecl.2018.11.005">https://dx.doi.org/10.1016/j.ecl.2018.11.005</a> |
Public note |
https://dx.doi.org/10.1016/j.ecl.2018.11.005 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |